Home › Seattle Genetics' Antibody Drug Conjugate Tech Prominent at ASCO Meeting
 

Keywords :   


Seattle Genetics' Antibody Drug Conjugate Tech Prominent at ASCO Meeting

2014-06-01 13:32:00| Biotech - Topix.net

Seattle Genetics, the company that pioneered the antibody-drug conjugate platform in Adcetris, the Hodgkin's lymphoma treatment, has data presented from a handful of collaborator programs at the American Society of Clinical Oncology's 50th Annual Meeting being held May 30 to June 3, 2014 in Chicago, IL.

Tags: tech meeting drug seattle

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Tropical Storm Beryl Forecast Discussion Number 30
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Tropical Storm Beryl Forecast Advisory Number 30
06.07Post-Tropical Cyclone Aletta Graphics
06.07Post-Tropical Cyclone Aletta Wind Speed Probabilities Number 7
06.07Post-Tropical Cyclone Aletta Forecast Advisory Number 7
06.07Post-Tropical Cyclone Aletta Public Advisory Number 7
06.07Summary for Post-Tropical Cyclone Aletta (EP1/EP012024)
More »